Reminders for Managing Ulcerative Colitis: Medication and Flare Monitoring

Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon. Its cyclical nature — periods of remission punctuated by flares — creates a specific adherence challenge: medication must be taken consistently even when the person feels completely well. Stopping or reducing medication during remission is the most common cause of preventable flares, yet the absence of symptoms makes continued treatment feel unnecessary. Phone-call reminders provide the consistent external prompt that makes maintenance therapy possible.

Maintenance Medication in Remission

The cornerstone of UC maintenance therapy is mesalazine (5-ASA), available as oral tablets, granules, suppositories, or enemas depending on disease extent. Oral mesalazine is typically taken twice daily; rectal preparations may be used nightly or several times weekly. The consistency requirement doesn't change in remission — stopping mesalazine allows mucosal inflammation to return.

For moderate-to-severe UC, immunosuppressants (azathioprine, 6-mercaptopurine) and biologics (infliximab, vedolizumab, ustekinumab) are used for maintenance. Biologics are administered at fixed intervals: infliximab every 8 weeks, vedolizumab every 8 weeks, ustekinumab every 12 weeks. Missing infusion appointments or injection dates allows drug levels to fall and inflammation to return.

A daily reminder for oral medication and a calendar-based reminder for biologic infusion dates creates the complete prompt system that UC maintenance requires.

Flare Detection and Early Response

Early flare detection allows prompt intensification of treatment before severe inflammation develops. The warning signs — increased stool frequency, rectal bleeding, urgency, nocturnal symptoms — are most reliably caught by consistent daily symptom monitoring.

A daily evening symptom check prompt — 'UC diary: rate today's symptoms — frequency, blood, urgency (0-3)' — provides the data trail that allows both the patient and their gastroenterologist to spot deterioration early. Patients who track symptoms consistently are more likely to contact their IBD team at the right time rather than waiting until a severe flare develops.

An escalation prompt — triggered when symptoms worsen — can remind the patient to contact their IBD nurse or GP without delay: 'If symptoms have worsened this week, call your IBD team today — early intervention prevents hospital admission.'

Monitoring Appointments and Investigations

UC monitoring includes regular blood tests (FBC, CRP, albumin, drug levels for biologics), stool calprotectin testing, and endoscopic surveillance. These appointments are easy to defer — particularly during remission when urgency is low — but are clinically important for detecting subclinical inflammation, drug toxicity, and colorectal cancer risk (elevated in long-standing UC).

Setting recurring reminders to book monitoring tests in advance — 'Time to book your UC blood test and calprotectin — due this month' — ensures timely completion without the patient needing to actively track the schedule.

Set up your complete UC management reminder at reminderit.com.